At the core of Aenitis’ innovation is a sole-in-class acoustic levitation system, enabling precise, non-invasive manipulation of cells in continuous flow at the millifluidic scale.
This disruptive gentle cell handling approach has no mechanical stress, is contactless and permits to increase overall yields, seamlessly scaling from proof-of-concept to GMP manufacturing.

Within a Modular Type Package (MTP) business model, acoustic cell handling steps can be integrated into existing workflows : sorting, washing, isolation, or concentration, offering flexible and GMP-ready solutions. In parallel, our modular production plant model enables rapid prototyping and scalable manufacturing of single-use consumables, from early clinical volumes to large-scale commercial production.

Together, these capabilities set new standards for quality, scalability, and efficiency in biotech and biopharma bioprocessing. Enabling accessibility: Supports the production of safe, effective, and high-quality therapies.

Unlocking new possibilities: Acoustic manipulation opens new avenues for optimizing bioprocess steps, enabling therapies that were previously challenging with conventional approaches.